Matches in SemOpenAlex for { <https://semopenalex.org/work/W2587831284> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2587831284 abstract "Abstract Abstract 4923 Objective To explore the safety and clinic therapeutic effects of using tumor activated dendritic cells (DC) accompanied cytokine induced killer (CIK) in order to feinforce opposing anti-tumor function and to eliminate minimal residual disease. Methods 59 patients entered into DCIK plus chemotherapy consolidation teams as achieved the 1st complete remission and after 1 or 2 cycle themotherapy. Collect 56 case's bone marrow monocyte cells at diagnosising to prepare tumor antigen, Collect bone marrow monocyte cells at complete remission to culture DC and CIK, using tumor antigen to activate DCs. After 7 days culturing separately then co-culture together for 1 day, collect these cells as DCs activated CIK, after scrubbing, infusing back to patients. Then these patients accept 10–15 day's immuno-regulation treatment, such as interleukine-2(IL-2) 500000u/d for one week or interferon -α(IFN-α)3,000,000u/d three times one week or thymopentin 1mg/d,2 times every week for two weeks. Those cases (one case AML-M3a,one case ALL-B,one case AML-M4a)only have routine culturing and infusion of DCs and CIK and the DCs are not activated by tumor antigen because of having no conservation leukemic cells. Results 59 cases accept DCIK immuno-therapy for 6 to 16 times respectively, in the 24 to 78 months observation stage, 42 cases OS(overall survival)and 33 cases DFS(disease free survival). No one developed therapeutic-dependent auto-allergic disease, such as fever, swollen, diarrhea, rash et al. Those three cases who accepted routine culturing and infusion of CIK and DCs that had not activated by tumor antigen didn't occure any treatment-dependency side-effects and keep hematologic complete remission, minimal residual disease test outcome persist lower under 103. Conclusion Tumor antigen activated DCs combined with CIK can reinforce anti-tumor immune function and have no obviously side-effects,accompanying with chemotherapy,those patients maybe benefit of this kind consolidation treatment and avoid routine chemo-therapeutic side reaction, temporary curative effect are satisfaction and worth popularized. Disclosures: No relevant conflicts of interest to declare." @default.
- W2587831284 created "2017-02-24" @default.
- W2587831284 creator A5020410077 @default.
- W2587831284 creator A5021145170 @default.
- W2587831284 creator A5035991874 @default.
- W2587831284 creator A5039494205 @default.
- W2587831284 creator A5063720832 @default.
- W2587831284 creator A5065696059 @default.
- W2587831284 creator A5066716873 @default.
- W2587831284 creator A5069168079 @default.
- W2587831284 creator A5072198686 @default.
- W2587831284 creator A5078615632 @default.
- W2587831284 creator A5081321173 @default.
- W2587831284 creator A5082276415 @default.
- W2587831284 creator A5085174853 @default.
- W2587831284 date "2011-11-18" @default.
- W2587831284 modified "2023-09-26" @default.
- W2587831284 title "Using Auto Dendritic Cells Accompanied with CIK Plus Chemotherapy As Consolidation Treatment for 59 Patients with Acute Leukemia" @default.
- W2587831284 doi "https://doi.org/10.1182/blood.v118.21.4923.4923" @default.
- W2587831284 hasPublicationYear "2011" @default.
- W2587831284 type Work @default.
- W2587831284 sameAs 2587831284 @default.
- W2587831284 citedByCount "0" @default.
- W2587831284 crossrefType "journal-article" @default.
- W2587831284 hasAuthorship W2587831284A5020410077 @default.
- W2587831284 hasAuthorship W2587831284A5021145170 @default.
- W2587831284 hasAuthorship W2587831284A5035991874 @default.
- W2587831284 hasAuthorship W2587831284A5039494205 @default.
- W2587831284 hasAuthorship W2587831284A5063720832 @default.
- W2587831284 hasAuthorship W2587831284A5065696059 @default.
- W2587831284 hasAuthorship W2587831284A5066716873 @default.
- W2587831284 hasAuthorship W2587831284A5069168079 @default.
- W2587831284 hasAuthorship W2587831284A5072198686 @default.
- W2587831284 hasAuthorship W2587831284A5078615632 @default.
- W2587831284 hasAuthorship W2587831284A5081321173 @default.
- W2587831284 hasAuthorship W2587831284A5082276415 @default.
- W2587831284 hasAuthorship W2587831284A5085174853 @default.
- W2587831284 hasConcept C126322002 @default.
- W2587831284 hasConcept C143998085 @default.
- W2587831284 hasConcept C147483822 @default.
- W2587831284 hasConcept C203014093 @default.
- W2587831284 hasConcept C2776694085 @default.
- W2587831284 hasConcept C2779823535 @default.
- W2587831284 hasConcept C2780007613 @default.
- W2587831284 hasConcept C71924100 @default.
- W2587831284 hasConcept C83396363 @default.
- W2587831284 hasConceptScore W2587831284C126322002 @default.
- W2587831284 hasConceptScore W2587831284C143998085 @default.
- W2587831284 hasConceptScore W2587831284C147483822 @default.
- W2587831284 hasConceptScore W2587831284C203014093 @default.
- W2587831284 hasConceptScore W2587831284C2776694085 @default.
- W2587831284 hasConceptScore W2587831284C2779823535 @default.
- W2587831284 hasConceptScore W2587831284C2780007613 @default.
- W2587831284 hasConceptScore W2587831284C71924100 @default.
- W2587831284 hasConceptScore W2587831284C83396363 @default.
- W2587831284 hasLocation W25878312841 @default.
- W2587831284 hasOpenAccess W2587831284 @default.
- W2587831284 hasPrimaryLocation W25878312841 @default.
- W2587831284 hasRelatedWork W148737360 @default.
- W2587831284 hasRelatedWork W207045108 @default.
- W2587831284 hasRelatedWork W2348202375 @default.
- W2587831284 hasRelatedWork W2354165459 @default.
- W2587831284 hasRelatedWork W2357752969 @default.
- W2587831284 hasRelatedWork W2365088759 @default.
- W2587831284 hasRelatedWork W2369224914 @default.
- W2587831284 hasRelatedWork W2370384541 @default.
- W2587831284 hasRelatedWork W2371189755 @default.
- W2587831284 hasRelatedWork W2376732567 @default.
- W2587831284 hasRelatedWork W2380062679 @default.
- W2587831284 hasRelatedWork W2382865481 @default.
- W2587831284 hasRelatedWork W2390239342 @default.
- W2587831284 hasRelatedWork W2391675471 @default.
- W2587831284 hasRelatedWork W2396142480 @default.
- W2587831284 hasRelatedWork W2523141632 @default.
- W2587831284 hasRelatedWork W2580474643 @default.
- W2587831284 hasRelatedWork W2590599835 @default.
- W2587831284 hasRelatedWork W3142462077 @default.
- W2587831284 hasRelatedWork W3146437349 @default.
- W2587831284 isParatext "false" @default.
- W2587831284 isRetracted "false" @default.
- W2587831284 magId "2587831284" @default.
- W2587831284 workType "article" @default.